As always, your information will not be sold or shared with anyone. See our privacy policy for more information.
NOTE: This study is only open to patients not currently under the care of a physician for opioid dependence and are seeking a treatment provider.
Please call 1-866-455-8876 between 9:00 AM to 7:30 PM EST to get more information.



HereToHelpProgram.com respects your privacy.
Read our Privacy Policy for more information.
In 2003, an estimated 21.6 million Americans were classified as having a substance use disorder (9.1% of the population ages 12 and older).1
The nature of medicine gives physicians and nurses "the best opportunity" to intervene and interrupt the progression of substance abuse.2 However, most medical schools devote only a few hours to the topic.2 According to surveys conducted in 2000 by Columbia University, 94% of primary care physicians failed to diagnose substance abuse in patients who displayed "classic symptoms."2
Screening for opioid dependence is similar to screening for other chronic medical conditions: Disease symptoms and risk factors are detectable through a routine patient interview or physical examination.
Several of the physical and behavioral symptoms associated with opioid use are itemized in the lists below (these lists are not intended as diagnostic tools):
Physical Signs of Opioid Intoxication
Physical Signs of Opioid Overdose
Physical Signs of Opioid Misuse
Psychosocial Signs of Opioid Dependence
DSM-IV Criteria for Substance Dependence
Physicians who believe a patient's symptoms warrant further screening are encouraged to do so (see Encouraging Patients to Open Up and General Guidelines for Screening Questions for techniques to help facilitate more effective patient communication).
Alternatively, if a patient's needs (in addition to possible dependence) exceed what can reasonably be addressed through your practice, you may want to consider referring that patient to another DATA 2000 certified physician.
Additional screening consideration: Laboratory tests (ie, blood or urine tests) for opioids are generally not recommended as routine screening tools, because in the absence of a comprehensive substance use assessment, positive results are still considered insufficient basis for a diagnosis of dependence.3,4
Laboratory tests are, however, commonly used to confirm a diagnosis of opioid dependence.3
Additional Resources
Physical Signs of Opioid Intoxication3
DSM-IV Criteria for Substance Dependence
Once a thorough patient assessment has been performed, a formal diagnosis of opioid dependence can be made. A substance dependence diagnosis, according to current Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) diagnostic schema, is based on clusters of behaviors and physiologic effects occurring within a specific time frame.7 A diagnosis of dependence always takes precedence over that of abuse, ie, a diagnosis of abuse is made only if the DSM-IV criteria for dependence have never been met.7
| DEPENDENCE | ABUSE |
| 3 or more in a 12-month period | 1 or more in a 12-month period (Symptoms must never have met criteria for dependence) |
| Tolerance (marked increase in amount; marked decrease in effect) | Recurrent use resulting in failure to fulfill major role obligation at work, home, or school |
| Characteristic withdrawal symptoms; substance taken to relieve withdrawal | Recurrent use in physically hazardous situations |
| Substance taken in larger amount and for longer period than intended | Recurrent substance-related legal problems |
| Persistent desire or repeated unsuccessful attempt to quit | Continued use despite persistent or recurrent social or interpersonal problems caused or exacerbated by substance |
| Much time/activity to obtain, use, recover | |
| Important social, occupational, or recreational activities given up or reduced | |
| Use continues despite knowledge of adverse consequences (eg, failure to fulfill role obligation, use when physically hazardous) |
In using the DSM-IV criteria, one should specify whether substance dependence is with physiologic dependence (ie, there is evidence of tolerance or withdrawal) or without physiologic dependence (ie, no evidence of tolerance or withdrawal). In addition, patients may be variously classified as currently manifesting a pattern of abuse or dependence or as in remission. Those in remission can be divided into 4 subtypes—full, early partial, sustained, and sustained partial—on the basis of whether any of the criteria for abuse or dependence have been met and over what time frame. The remission category can also be used for patients receiving agonist therapy (eg, methadone maintenance) or for those living in a controlled drug-free environment.
| 1. | Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2003 national survey on drug use and health: national findings. Rockville, Md: Department of Health and Human Services, SAMHSA, Office of Applied Studies; 2004. NSDUH Series H–25, DHHS Publication No. SMA 04-3964. |
| 2. | National Center on Addiction and Substance Abuse at Columbia University (CASA). Missed Opportunity: National Survey of Primary Care Physicians and Patients on Substance Abuse. New York: CASA, 2000. |
| 3. | Center for Substance Abuse Treatment (CSAT). Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004. |
| 4. | Detection and Diagnosis of Opioid Dependence [CME course]. Available at: http://www.addictionCME.com. Accessed June 7, 2004. |
| 5. | Buprenorphine in the Treatment of Opioid Dependence [training CD-ROM]. Prairie Village, Kan: American Academy of Addiction Psychiatry; 2002. |
| 6. | Education center: is it something other than pain? Partners Against Pain website. Available at: partnersagainstpain.com/index-mp.aspx?sid=2&aid=7697. Accessed March 22, 2005. |
| 7. | Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. Text Revision. Washington, DC: American Psychiatric Association; 2000. |